Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

narmac

Rank: Vice President [?]

Points: 3973 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program

in response to

Re: Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program

Albertaclipper

posted on Mar 18, 2019 01:01PM

AC,,,,,,I'll say Pfizer will take us out sometime mid summer right after the BoM results,,,, that should help with the buyout price being even much more in our favour,,,,hahhaha,,,,I will vote for your idea first however!!,,,,,,thumbs up!!!

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply